标题
Therapeutic advances in anaplastic thyroid cancer: a current perspective
作者
关键词
-
出版物
Molecular Cancer
Volume 17, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-10-23
DOI
10.1186/s12943-018-0903-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer
- (2018) Vivek Subbiah et al. JOURNAL OF CLINICAL ONCOLOGY
- JAK inhibitors to suppress paclitaxel-resistant anaplastic thyroid cancer via IL-6 reduction.
- (2018) Tomoyuki Fujita et al. JOURNAL OF CLINICAL ONCOLOGY
- Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells
- (2017) Kirk Jensen et al. ENDOCRINE-RELATED CANCER
- CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy
- (2017) Karen Zwaenepoel et al. HISTOPATHOLOGY
- Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis
- (2017) Silvia Cantara et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study
- (2017) Ashish V. Chintakuntlawar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer
- (2017) Revathi Kollipara et al. ONCOLOGIST
- Reintroducing the Sodium–Iodide Symporter to Anaplastic Thyroid Carcinoma
- (2017) Kathrin A. Schmohl et al. THYROID
- Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells
- (2017) Si Hyoung Kim et al. TUMOR BIOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Leveraging the immune system to treat advanced thyroid cancers
- (2017) Jena D French et al. Lancet Diabetes & Endocrinology
- Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model
- (2017) Liya Zhu et al. Frontiers in Immunology
- Generation of Novel Thyroid Cancer Stem-Like Cell Clones
- (2016) Heather Hardin et al. AMERICAN JOURNAL OF PATHOLOGY
- Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base
- (2016) Todd A. Pezzi et al. CANCER
- Lenvatinib: Role in thyroid cancer and other solid tumors
- (2016) Maria E. Cabanillas et al. CANCER TREATMENT REVIEWS
- Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC)
- (2016) J. Abdulghani et al. CLINICAL CANCER RESEARCH
- Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model
- (2016) Xuguang Zhu et al. CLINICAL CANCER RESEARCH
- 1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest
- (2016) Wen Peng et al. ENDOCRINE RESEARCH
- MCM5 as a target of BET inhibitors in thyroid cancer cells
- (2016) Catia Mio et al. ENDOCRINE-RELATED CANCER
- Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
- (2016) David Viola et al. ENDOCRINE-RELATED CANCER
- The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis
- (2016) Jeanny Kwon et al. EUROPEAN JOURNAL OF CANCER
- Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival
- (2016) Scott M. Glaser et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer
- (2016) Jill J. Bastman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Biologic and Clinical Perspectives on Thyroid Cancer
- (2016) James A. Fagin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells
- (2016) LORENZO ALLEGRI et al. ONCOLOGY REPORTS
- Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion
- (2016) Peter T. White et al. SURGERY
- Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial
- (2016) Maria Graziella Catalano et al. International Journal of Endocrinology
- Selective use of sorafenib in the treatment of thyroid cancer
- (2016) Fabián Pitoia et al. Drug Design Development and Therapy
- Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosis
- (2016) Devora Champa et al. Oncotarget
- Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer
- (2016) Eran Brauner et al. Oncotarget
- Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer
- (2015) Min Zhou et al. BIOMATERIALS
- Radioactive 125I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway
- (2015) Yunhong Tian et al. BMC CANCER
- MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential
- (2015) Kun-Chun Chiang et al. CANCER LETTERS
- Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer
- (2015) A. Mehta et al. CLINICAL CANCER RESEARCH
- Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer
- (2015) A. Mehta et al. ENDOCRINE-RELATED CANCER
- Differential effects of MAPK pathway inhibitors on migration and invasiveness of BRAFV600E mutant thyroid cancer cells in 2D and 3D culture
- (2015) Camilla Ingeson-Carlsson et al. EXPERIMENTAL CELL RESEARCH
- Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 Synergizes With the Histone Deacetylase Inhibitor PXD101 in Induction of Death of Anaplastic Thyroid Carcinoma Cells
- (2015) Si Hyoung Kim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Novel Dual AMPK Activator/mTOR Inhibitor Inhibits Thyroid Cancer Cell Growth
- (2015) Robert L. Plews et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target
- (2015) Christina A. von Roemeling et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Deregulation of EGFR/PI3K and activation of PTEN by photodynamic therapy combined with carboplatin in human anaplastic thyroid cancer cells and xenograft tumors in nude mice
- (2015) Raktim Biswas et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Anaplastic Thyroid Carcinoma, Version 2.2015
- (2015) Robert I. Haddad et al. Journal of the National Comprehensive Cancer Network
- Lenvatinib and radioiodine-refractory thyroid cancers
- (2015) Lara Dunn et al. Nature Reviews Endocrinology
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer
- (2015) DOUGLAS W. BALL et al. ONCOLOGY REPORTS
- Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line
- (2015) Federica Baldan et al. International Journal of Endocrinology
- Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis
- (2015) Samira M. Sadowski et al. Oncotarget
- The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma
- (2015) Carmela Passaro et al. Oncotarget
- Hesperetin Activates the Notch1 Signaling Cascade, Causes Apoptosis, and Induces Cellular Differentiation in Anaplastic Thyroid Cancer
- (2014) Priyesh N. Patel et al. ANNALS OF SURGICAL ONCOLOGY
- Is Poorly Differentiated Thyroid Cancer Poorly Characterized?
- (2014) Kenneth D. Burman JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of Salvage Targeted Therapy in Differentiated Thyroid Cancer Patients Who Failed First-Line Sorafenib
- (2014) Ramona Dadu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth
- (2014) Eric Weinlander et al. JOURNAL OF SURGICAL RESEARCH
- PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma
- (2014) Carmela Passaro et al. Molecular Oncology
- Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
- (2014) Nikhil Wagle et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Aurora in Anaplastic Thyroid Cancer Therapy
- (2014) Enke Baldini et al. International Journal of Endocrinology
- Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
- (2014) Moira Ragazzi et al. International Journal of Endocrinology
- Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways
- (2014) V Gunda et al. Cell Death & Disease
- A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes
- (2013) S. M. Lim et al. ANNALS OF ONCOLOGY
- Valproic Acid Sensitizes TRAIL-Resistant Anaplastic Thyroid Carcinoma Cells to Apoptotic Cell Death
- (2013) Hyun-Young Cha et al. ANNALS OF SURGICAL ONCOLOGY
- Ionizing radiation enhances dl922–947-mediated cell death of anaplastic thyroid carcinoma cells
- (2013) Carmela Passaro et al. ENDOCRINE-RELATED CANCER
- Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
- (2013) R. C. Smallridge et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
- (2013) Marina N. Nikiforova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth
- (2013) X.-M. Yu et al. MOLECULAR CANCER THERAPEUTICS
- Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
- (2013) Alan L. Ho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression
- (2013) Mabel Ryder et al. PLoS One
- Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer
- (2013) C. R. Isham et al. Science Translational Medicine
- Histone Deacetylase Inhibition Affects Sodium Iodide Symporter Expression and Induces 131I Cytotoxicity in Anaplastic Thyroid Cancer Cells
- (2013) Mariateresa Pugliese et al. THYROID
- The PLK1 Inhibitor GSK461364A Is Effective in Poorly Differentiated and Anaplastic Thyroid Carcinoma Cells, Independent of the Nature of Their Driver Mutations
- (2013) Marika A. Russo et al. THYROID
- Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma
- (2013) Julie A. Sosa et al. THYROID
- New Targeted Therapies for Anaplastic Thyroid Cancer
- (2012) Alessandro Antonelli et al. Anti-Cancer Agents in Medicinal Chemistry
- Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo
- (2012) Xiao-Min Yu et al. CANCER
- Aurora A kinase (AURKA) in normal and pathological cell division
- (2012) Anna S. Nikonova et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Glycolytic Inhibition Alters Anaplastic Thyroid Carcinoma Tumor Metabolism and Improves Response to Conventional Chemotherapy and Radiation
- (2012) Vlad C. Sandulache et al. MOLECULAR CANCER THERAPEUTICS
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
- (2012) Robert C. Smallridge et al. THYROID
- Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer
- (2011) Annette Wunderlich et al. CANCER SCIENCE
- Late Intervention with anti-BRAFV600ETherapy Induces Tumor Regression in an Orthotopic Mouse Model of Human Anaplastic Thyroid Cancer
- (2011) Matthew A. Nehs et al. ENDOCRINOLOGY
- Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma
- (2011) Bernard Caillou et al. PLoS One
- Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model
- (2009) Yong Jin Lee et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling Pathways
- (2009) Peng Hou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation
- (2009) E Borbone et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started